Effects of Nebivolol and Atenolol on Central Aortic Depression in Patients with Hypertension

Trial Profile

Effects of Nebivolol and Atenolol on Central Aortic Depression in Patients with Hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2014

At a glance

  • Drugs Nebivolol (Primary) ; Atenolol
  • Indications Essential hypertension; Hypertension
  • Focus Pharmacodynamics
  • Sponsors Laboratorios Menarini
  • Most Recent Events

    • 01 Jun 2014 Status changed from recruiting to completed, according to results published in the Blood Pressure.
    • 30 Aug 2011 EudraCT record identified as additional data source and relevant information added
    • 30 Aug 2011 Status changed from completed to recruiting , as reported in the EudraCT record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top